Back
CrowdStrike Holdings Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
81
CRWD
CrowdStrike Holdings
Last Price:
386.90
Seasonality Move:
9.22%
Buy
53
SRPT
Sarepta Therapeutics
Last Price:
158.06
Seasonality Move:
18.65%
Buy
81
CrowdStrike Holdings (CRWD)
is a Buy
Is CrowdStrike Holdings a Buy, Sell or Hold?
- The current CrowdStrike Holdings [CRWD] share price is $380.37. The Score for CRWD is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- CRWD is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
53
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $156.91. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRWD Stock Price Chart
What is CrowdStrike Holdings's stock price today?
-
The CrowdStrike Holdings share price today is $380.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRWD is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $156.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRWD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.73 | Buy |
| Relative Strength Index (14 RSI): | 61.01 | Buy |
| Chaikin Money Flow: | -2345294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (331.44 - 385.58) | Buy |
| Bollinger Bands (100): | (301.14 - 352.46) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.17 | Buy |
| Relative Strength Index (14 RSI): | 68.43 | Buy |
| Chaikin Money Flow: | 1613298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.82 - 142.64) | Buy |
| Bollinger Bands (100): | (118.8 - 136.1) | Buy |
CRWD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 384.19 | Sell |
| 20-day SMA: | 361.38 | Buy |
| 50-day SMA: | 334.7 | Buy |
| 200-day SMA: | 272.69 | Buy |
| 8-day EMA: | 380.57 | Sell |
| 20-day EMA: | 367.57 | Buy |
| 50-day EMA: | 345.6 | Buy |
| 200-day EMA: | 282.95 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 140.03 | Buy |
| 20-day SMA: | 129.22 | Buy |
| 50-day SMA: | 127.95 | Buy |
| 200-day SMA: | 115.45 | Buy |
| 8-day EMA: | 145.32 | Buy |
| 20-day EMA: | 134.79 | Buy |
| 50-day EMA: | 129.39 | Buy |
| 200-day EMA: | 120.67 | Buy |
CrowdStrike Holdings Earnings Growth & CRWD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.17 per share, an increase this year of $1.46 per share, and an increase next year of $1.06 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
CrowdStrike Holdings Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||